Acne Treatment Market

Growing Accessibility to Product and Services like OTC Products and Cosmetic Laser Options for Acne Treatment will propel the Market Growth

Acne Treatment Market Segmented By Acne Therapeutics, Acne Medication, Acne Antibiotics Market, Conventional Acne Treatments, Dermatologists Diagnose Acne

Report ID: PMRREP5279

Number of Pages: 261

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Published Date: December-2022

Report Price

$4900*

Buy Now

Acne Treatment Market Outlook (2023-2033)

Worldwide revenue from the acne treatment market stands at US$ 6.5 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 5.8% to reach a valuation of US$ 12.0 Bn by the end of 2033.

Attribute

Details

Acne Treatment Market Size (2022)

US$ 6.5 Bn

Projected Market Value (2033)

US$ 12.0 Bn

Global Market Growth Rate (2023-2033)

5.8% CAGR

Market Share of Top 4 Countries

52.5%

As assessed by Persistence Market Research, therapeutic treatment is expected to hold a largest market value of US$ 5.4 Bn by 2023. Overall, acne treatment market sales account for approximately 6.5% revenue share in the global skincare market, which was valued at around US$ 100.1 Bn at the end of 2022.

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get Report Sample

Sales Analysis of the Global Market from 2016 to 2022 Vs Market Outlook for 2023 to 2033

The global market for acne treatment recorded a historic CAGR of 4.4% in the last 6 years from 2016 to 2022.

Worldwide, early start of acne vulgaris is being influenced by late fertility, childbirth, and cyclically early puberty in teenagers. The average age at which acne vulgaris first appears has dropped from 14-15 to 11-12 years. Additionally, the media's growing negative influence is encouraging a bad habit of self-medication. According to estimates, 20% of children (under the age of 13) suffer from moderate-to-severe acne, and the severity of the condition is highly correlated with pubertal development. Obesity and distorted eating behaviors, such as fried and ready-to-eat meals among school-aged children, are also thought to contribute to acne vulgaris.

The use of various OTC (over-the-counter) products is being driven by rising disposable income levels globally, primarily as a means of treating acne and enhancing physical appearance. The benefit is that rising patient demand for over-the-counter drugs increases market revenues as a whole. A typical OTC product costs between $150 and $500 USD. A cosmetic laser treatment for acne typically costs between $150 and $350. Accessibility to these services and products is a major factor in development of the market.

Growing demand for acne treatment products is being fueled by an increase of dermatological clinics around the world, particularly in Thailand, India, and South Korea. Optimizing adherence and outcomes is more likely to occur when effective yet well-tolerated regimens with straightforward doses that suit patient lifestyles are designed. The key factors anticipated to drive the revenue growth of the acne treatment market are the accessibility of well skilled doctors who can effectively include patients in treatment designing.

Increased marketing results in increased product sales. Along with radio and TV commercials, celebrity endorsements of top companies' products have a tendency to affect target customers' inclination to buy. In order to increase their market share, players in the industry are therefore spending more money on sales, marketing, and advertising in addition to R&D projects.

The global market is thus likely to show high growth over the coming years at a CAGR of 5.8% and reach a global market size of US$ 11.9 Bn by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What Factors Will Drive the Market to Grow Over Forecast Period?

Rising uptake of combination treatments

Combination acne treatments are becoming more popular, which opens up with potential increased sales. Targeting several pathogenic variables is made easier by combination products like benzoyl peroxide + antibiotic and retinoid + antibiotic. According to research, benzoyl peroxide 2.5% + clindamycin is just as effective as benzoyl peroxide 5% + clindamycin at treating non-inflammatory lesions. Through direct sales tactics used by manufacturers to practitioners, the usage of combination therapies can be expanded. This can encourage revenue growth.

“Increasing demand for faster treatment and quicker results”

The demand for equipment-based therapies like lasers is anticipated to increase as patients desire quicker treatments and effective results. Laser treatments eliminate problems permanently and reduce the likelihood of developing new ones, such as more facial hair growth and pigmentation disorders. Additionally, laser treatments are less unpleasant than other types, which makes it simpler for patients to adapt. For instance, medical professionals advise using combination therapy, such as combining a topical antibiotic with a retinoid, to permanently reduce the occurrence of acne.

“Expansion of formulated range of product lines”

To improve the revenue base from topical acne treatment medicines, manufacturers are offering a wider range of Rx-formulated products. Customers' rejection of the "one size fits all" strategy is the main reason why this is happening. Companies must manufacture at least eight to ten variations of products, for instance, moisturizers based on the type of skin, the geography, the potency of the active ingredients, etc. Greater product personalization and increased demand for the product among the patient will develop the acne treatment market.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Is there Any Impact on the Growth of the Acne Treatment Market?

Lack of long-term efficacy”

According to the AAD, there is a serious lack of long-term product efficacy studies and data, which causes consumers to stop using certain products. Furthermore, due to prejudice brought on by a biased selection of the clinical trial population, differences in skin types, etc., the lack of data also causes a knowledge gap between regional research forums. The company's product R&D is hampered by the lack of long-term data since scientists have a narrow view of the feasibility of their products. In developed markets, where customers and patients typically conduct their own research before deciding to purchase a therapy or product, this also tends to have an impact on the depth of product penetration.

“Adverse Side Effects Related Different Acne Treatment Products”

Depending on the medication, different acne treatments have different side effects.

The most common harmful effects of topical acne medications are dryness and irritation of the skin. As the body adjusts to the drug, these symptoms frequently get worse. One should see a doctor if their skin is really itchy, burning, or peeling. For oral drugs, there may be more severe adverse effects. Antibiotics may cause stomach discomfort or make you feel faint and dizzy. One should use a backup birth control method if the person is also taking birth control pills. Some antibiotics decrease the effectiveness of birth control pills' ability to prevent pregnancy.

Country-wise Insights

Why is the U.S. Market Booming?

“Growing Adoption of Acne Treating Products”

The U.S. accounted for around 90.1% market share in the North America acne treatment market in 2022.

The adoption of acne treating products in the country is anticipated to increase due to the increased prevalence of acne procedures. The increasing need for efficient medical procedures may lead to more acne treatment options. For instance, according to data from the American Academy of Dermatology (AAD), acne vulgaris affects more than 50 million people, 85% of whom are adults and teenagers, is the most often diagnosed condition in the U.S. is anticipated to fuel the U.S. market.

Will Germany Be a Lucrative Market for Acne Treatment Manufacturers?

“High Per Capita Healthcare Spending”

With a 22.9% market share, Germany dominates the market in Europe in 2022.

The healthcare expenditure per capita is rising globally. Healthcare spending has significantly changed as a result of people's capacity and willingness to spend on wellness. Compared to the other European countries, Germany spends more money per capita on healthcare (around 11.2% of GDP), and it provides a variety of benefits packages, high-quality service delivery, and simple access to care.

Additionally, the country's access to acne treatment solutions is improved by the presence of manufacturing facilities. Players are also working together on research projects to create efficient acne treatment options.

How is Japan Emerging as a Prominent Market for Acne Treatment?

“Advertisement and Endorsement by Influencers and Celebrities”

Japan held a market share of about 45.7% of the East Asia acne treatment market in 2022.

Key players are seeing lucrative potential in the cosmetics market due to the growing use of retinoid creams, gels, and lotions for anti-ageing and to increase collagen levels. The growing concerns about the prevalence of acne and other skin problems across the country are anticipated to fuel market growth. Additionally, with influencer and celebs endorsement on the rise and an increase in the number of beauty and skincare products by celebrities and influencers launching their own product lines, the market is expected to see an increase in revenue over the forecast period.

  • For instance, in 2021, Japanese star Becky launched her own direct-to-consumer skincare line, NaturaLUNA, using the D2C platforms offered by AnyMind Group, including AnyFactory, AnyShop, and AnyLogi.

Category-wise Insights

Which Product is Driving Growth of the Global Market?

“Higher Demand in Patient Pool”

Therapeutic treatment held the largest market share of the total acne treatment market in 2022. This segment is further expected to hold a largest market value of US$ 5.4 Bn by 2023

The high demand for these products due to their competency for a range of different skin types, ease, and cost effectiveness in contrast to other treatment options are one of the key factors influencing category growth.

A significant success rate in product development, new product launches, and treatment approvals are further key factors supporting the growth of the product category.

Which Route of Administration Has Dominated the Acne Treatment Market Globally?

“Wide Availability, Easy Access and Higher Demand Amongst the Population”

Topical route of administration holds a major market share of around 61.6% in 2022. Due to their high demand among both men and women, topical acne treatment products like ointments and lotions that protect the skin from bacteria and skin illnesses like psoriasis and eczema are widely available in the market. They contain active ingredients like vitamin A or medicines like antibiotics for acne caused on by bacterial infections. Since acne is defined by blockage and inflammation, these products aid in clearing the pores and lowering inflammation.

Which Segment of Acne Type Has Dominated the Global Market?

Unhealthy Lifestyle Leading to Prevalence of Skin Disorders”

As of 2022, inflammatory acne has dominated the segment with major market share of about 53.5%.

Acne flare-ups and improper face washing, masturbation, and sex all have a connection. Based on specific research, inflammatory acne also brought on by high-glycemic diets and milk products. Hormonal changes brought on by pregnancy or the menstrual cycle, occlusive cosmetics, cleansers, lotions, high humidity, sweating, unhealthy lifestyle are some other reasons contributing to the high occurrence of inflammatory acne.

Which End User Offers the Global Market a Profitable Outlook?

“Growing Awareness Regarding Available Acne Treatment”

Institutional sales segment held the larger share of about 52.4% with a market value of around US$ 3.4 Bn in 2022.

Increasing numbers of dermatological clinics and greater acne treatment awareness have created lucrative market expansion potential. The primary motivating aspect has been patients' preferences for having direct interactions with doctors and pharmacists.

Competition Landscape

Mergers and acquisitions have become one of the major growth tactics used by market players, taking into account competitive efforts in the global market. A number of well-known companies are expanding their product lines through acquisitions and engaging with both established and developing markets.

Key instances include:

  • In March 2022, Differin, a well-known consumer acne medicine from Galderma Laboratories, L.P., the first FDA-approved, dermatologically tested, started a digital and audio advertising campaign that led to a strategic partnership with Acast Creative.
  • in Dec 2020, L’Oréal announced the signing of a deal to acquire Takami Co., a Japanese company. In Japan, Takami is a well-known brand in skin care.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the acne treatment market, which are available in the full report

Industry Report Scope

Attribute

Details

Forecast Period

2023-2033

Historical Data Available for

2016-2022

Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC
  • North Africa
  • South Africa

Key Market Segments Covered

  • Product
  • Route of Administration
  • Acne Type
  • End User
  • Region

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Key Companies’ Profile

  • Galderma S.A.
  • Lumenis Ltd
  • Alma Lasers, Sisram Medical Company
  • Cutera Inc.
  • Almirall, S.A
  • Johnson & Johnson Services Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Stiefel Laboratories, a GSK Company
  • Candela Medical

Customization & Pricing

Available upon Request

Key Segments Covered in Acne Treatment Industry Research

Product:

  • Therapeutic Treatment
    • Antibiotics
    • Retinoid Therapy
    • Hormonal Drugs
    • Anti-inflammatory drugs
    • Chemical Peels
  • Devices
    • Laser Devices
    • Radiofrequency Devices

Route of Administration:

  • Topical
  • Oral

Acne Type:

  • Inflammatory Acne
  • Non-Inflammatory Acne

End User:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

For report customisation and delivery information contact our sales representative.

Companies Covered in This Report

  • Bausch Health Companies Inc.
  • Galderma S.A.
  • Lumenis Ltd
  • Alma Lasers, Sisram Medical Company
  • Cutera Inc.
  • Almirall, S.A
  • Johnson & Johnson Services Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Stiefel Laboratories, a GSK Company
  • Candela Medical

Frequently Asked Questions

The global market is currently valued at around US$ 6.5 Bn in 2022.

Sales of the market are set to witness growth at a CAGR of 5.8% and be valued at around US$ 12.0 Bn by 2033.

Demand for the market increased at a 4.4% CAGR from 2016 to 2022.

U.S., Germany, Japan, and Australia accounted for the major share in the global market as of year 2022, holding around 52.5% market share.

The U.S. accounts for around 90.1% share of the North American market in 2022.

Latin America accounts for around 8.4% share of the global market in 2022.

Japan held a market share of about 45.7% of the East Asia acne treatment market in 2022.  

Germany held about 22.9% of the regional market share at the end of 2022.

Brazil is estimated to grow at a CAGR rate of 5.8% over the forecast period.

India will expand at CAGR of close to 9.6% during the forecast period.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate